Skip to main content
. Author manuscript; available in PMC: 2021 Oct 10.
Published in final edited form as: Placenta. 2010 Dec 3;32(2):134–139. doi: 10.1016/j.placenta.2010.11.004

Table 2.

Antibodies used in the study.

No. Name Company Cat. No. Dilution
1 Angiotensinogen Swant Inc. Switzerland 138 1:1000
2 Renin Santa Cruz Biotechnologies sc-27320 1:300
3 ACE-1 Abcam Inc. ab39172 1:1000
4 ACE-2 Abcam Inc. ab59351 1:1000
5 AT-1 Abcam Inc. ab59018 1:250
6 AT-2 Abcam Inc. ab19134 1:250
7 GAPDH Abcam Inc. ab9485 1:2000
8 Alpha-Actin Abcam Inc. Ab1801 1:1000
9 ERK1/2 Cell Signaling Technology #9102 1:1000
10 Beta-tubulin Santa Cruz Biotechnology sc-5274 1:1000